Adam Schechter sells 5,273 LH shares

Adam H. Schechter reported a sale of 5,273 common shares on 02/11/2026 for $1,499,535.74.

Rhea-AI Filing Summary

Adam H. Schechter reported a sale of 5,273 common shares on 02/11/2026 for $1,499,535.74.

The filing also lists restricted stock vesting events from the issuer on 02/06/2025 (1,528 shares), 02/06/2026 (3,145 shares), 02/07/2026 (1,897 shares) and 02/11/2026 (2,135 shares) shown as compensation vesting events.

Insights

Securities Compliance Analyst

Form 144 shows an affiliate sale and recent issuer vesting events.

The filing records a sale by Adam H. Schechter of 5,273 common shares on 02/11/2026 at an aggregate consideration of $1,499,535.74. This is disclosed under the section showing securities sold during the past three months.

The notice also lists multiple restricted stock vesting events dated between 02/06/2025 and 02/11/2026 totaling disclosed share amounts; these are identified as compensation vesting from the issuer. Timing and cash‑flow treatment for future sales are not detailed in the excerpt.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the Form 144 for LH report about Adam H. Schechter?

It reports a sale of 5,273 common shares on 02/11/2026 for $1,499,535.74. The filing also lists multiple issuer restricted stock vesting events in 2025–2026 totaling several thousand shares as compensation.

Does the filing show other stock events for LH besides the sale?

Yes. The filing lists restricted stock vesting events on 02/06/2025, 02/06/2026, 02/07/2026, and 02/11/2026 with share counts of 1,528, 3,145, 1,897, and 2,135, respectively.

How much cash did Adam H. Schechter receive from the reported sale?

The filing lists aggregate consideration of $1,499,535.74 for the sale of 5,273 shares on 02/11/2026. The excerpt pairs the share count and the aggregate sale amount in the securities-sold entry.

Are the vesting shares in the Form 144 being sold or merely vesting?

The document lists those entries as Restricted Stock Vesting and labels them as compensation from the issuer; it does not state these vested shares were sold in the provided excerpt.

Does the Form 144 disclose who received sale proceeds or future sale plans?

The filing shows the aggregate sale amount for the past sale but does not disclose who will receive proceeds from any future sales or detailed plans for disposition in the provided excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 12:23 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001376841
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	LABCORP HOLDINGS INC.
SEC File Number	001-11353
Address of Issuer	358 S MAIN ST BURLINGTON NORTH CAROLINA 27215
Phone	3362291127
Name of Person for Whose Account the Securities are To Be Sold	Schechter Adam H
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	8705	2437047.45	82400000	03/03/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/06/2025	Restricted Stock Vesting	Issuer			1528	02/06/2025	Compensation
Common	02/06/2026	Restricted Stock Vesting	Issuer			3145	02/06/2026	Compensation
Common	02/07/2026	Restricted Stock Vesting	Issuer			1897	02/07/2026	Compensation
Common	02/11/2026	Restricted Stock Vesting	Issuer			2135	02/11/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Adam H. Schechter 358 South Main Street Burlington NC 27215	Common	02/11/2026	5273	1499535.74

144: Remarks and Signature

Remarks
Date of Notice	03/03/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Audrey McMillen, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Adam H. Schechter
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)